{"schema_version":"secwatch.filing_event.v1","accession":"0001193125-26-007660","form_type":"8-K","ticker":"PHAT","cik":"0001783183","company_name":"Phathom Pharmaceuticals, Inc.","filed_at":"2026-01-08T23:59:59+00:00","discovered_at":"2026-05-14T18:02:36.161289+00:00","generated_at":"2026-05-16T11:14:24.858617+00:00","sec_items":["8.01","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.75,"calibrated_materiality_score":0.75,"confidence":"high","headline":"Phathom Pharmaceuticals prices $130M public offering of common stock and pre-funded warrants","bullets":["6,875,000 shares of common stock at $16.00/share and pre-funded warrants for 1,250,078 shares at $15.999/warrant.","Gross proceeds approximately $130M; underwriters have 30-day option for additional 1,218,761 shares.","Net proceeds for general corporate purposes, including working capital and R&D.","Offering expected to close on/about January 9, 2026; Guggenheim Securities and Cantor are joint bookrunners."],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-26-007660","json":"https://secwatch.observer/filing/0001193125-26-007660.json","markdown":"https://secwatch.observer/filing/0001193125-26-007660.md","text":"https://secwatch.observer/filing/0001193125-26-007660.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1783183/000119312526007660/0001193125-26-007660-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1783183/000119312526007660/d680858d8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-16T11:14:24.858617+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}